EVR:NYSEEvercore Inc. Analysis
Data as of 2026-06-17 - not real-time
$373.80
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Evercore (EVR) is trading at $373.8, just below its recent high of $374.75 and comfortably above its 20‑day ($346.88), 50‑day ($342.12) and 200‑day ($329.91) simple moving averages, indicating a strong bullish trend. The momentum is reinforced by a 14‑day RSI of 65 and a MACD histogram of +2.45, both signaling continued upside potential. However, the stock’s beta of 1.79 and 30‑day volatility of 36% suggest pronounced price swings, especially in a market environment flagged as “Extreme Greed” by the Fear & Greed Index. Fundamentally, EVR delivers exceptional profitability with a gross margin of 94% and an operating margin of 24%, while its ROE of 42% and ROA of 21% underscore efficient capital use. The company’s dividend yield of 0.95% is modest but sustainable, given a low payout ratio of 19% and ample operating cash flow. A discounted cash flow analysis places intrinsic value near $1,030, implying the market is pricing EVR at roughly one‑third of its fair value, a stark contrast to its sector P/E average of 17 versus EVR’s 21.
Despite a modest revenue growth of 0.3%, Evercore’s strong balance sheet—$986 M cash versus $1.1 B debt—and high return metrics position it well for long‑term upside. The recent participation of CEO John Weinberg in the Morgan Stanley U.S. Financials Conference highlights continued leadership visibility. Overall, the confluence of bullish technicals, deep undervaluation relative to intrinsic estimates, and solid fundamentals makes EVR a compelling candidate for investors willing to navigate its higher volatility.
Despite a modest revenue growth of 0.3%, Evercore’s strong balance sheet—$986 M cash versus $1.1 B debt—and high return metrics position it well for long‑term upside. The recent participation of CEO John Weinberg in the Morgan Stanley U.S. Financials Conference highlights continued leadership visibility. Overall, the confluence of bullish technicals, deep undervaluation relative to intrinsic estimates, and solid fundamentals makes EVR a compelling candidate for investors willing to navigate its higher volatility.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical indicators (price above SMAs, RSI 65, MACD bullish)
- Proximity to resistance with potential breakout
- Strong cash flow supporting dividend sustainability
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Valuation gap versus DCF fair value
- Stable earnings and high profit margins
- Elevated volatility that may cause interim pullbacks
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Intrinsic value upside of over 150% versus current price
- High ROE and consistent dividend with low payout ratio
- Robust balance sheet and seasoned management team
Key Metrics & Analysis
Financial Health
Revenue Growth100.30%
Profit Margin16.40%
P/E Ratio21.0
ROE42.17%
ROA21.35%
Debt/Equity52.59
P/B Ratio8.1
Op. Cash Flow$1.6B
Industry P/E17.1
Technical Analysis
TrendBullish
RSI65.0
Support$322.72
Resistance$374.75
MA 20$346.88
MA 50$342.12
MA 200$329.91
MACDBullish
VolumeStable
Fear & Greed Index92.13
Valuation
Fair Value$1,030.09
Target Price$374.60
Upside/Downside0.21%
GradeUndervalued
TypeBlend
Dividend Yield0.95%
Risk Assessment
Beta1.79
Volatility36.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.